[go: up one dir, main page]

BR9506244A - 5-(Citosinil-1)1,3-oxatiolanos de configuração cis (2r-5r)compostos nicotínicos compostos dihidropirídicos compostos nicotínicos quaternizados compostos quinolênicos compostos dihidroquinoleinila compostos quinoleinilas quaternizados compsotos (dihidropiridil alquila)sais de adição com ácido orgânico ou mineral isômeros oticamente ativos dos compostos processo para a produção de compostos e composições farmacêuticas com ação antiviral - Google Patents

5-(Citosinil-1)1,3-oxatiolanos de configuração cis (2r-5r)compostos nicotínicos compostos dihidropirídicos compostos nicotínicos quaternizados compostos quinolênicos compostos dihidroquinoleinila compostos quinoleinilas quaternizados compsotos (dihidropiridil alquila)sais de adição com ácido orgânico ou mineral isômeros oticamente ativos dos compostos processo para a produção de compostos e composições farmacêuticas com ação antiviral

Info

Publication number
BR9506244A
BR9506244A BR9506244A BR9506244A BR9506244A BR 9506244 A BR9506244 A BR 9506244A BR 9506244 A BR9506244 A BR 9506244A BR 9506244 A BR9506244 A BR 9506244A BR 9506244 A BR9506244 A BR 9506244A
Authority
BR
Brazil
Prior art keywords
compounds
quaternized
nicotinic
dihydropyridic
dihydroquinoleinyl
Prior art date
Application number
BR9506244A
Other languages
English (en)
Inventor
Anne-Sophie Charvet-Faury
Michel Camplo
Jean-Louis Kraus
Original Assignee
Laphal Laboratoires Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laphal Laboratoires Sa filed Critical Laphal Laboratoires Sa
Publication of BR9506244A publication Critical patent/BR9506244A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9506244A 1994-05-24 1995-05-24 5-(Citosinil-1)1,3-oxatiolanos de configuração cis (2r-5r)compostos nicotínicos compostos dihidropirídicos compostos nicotínicos quaternizados compostos quinolênicos compostos dihidroquinoleinila compostos quinoleinilas quaternizados compsotos (dihidropiridil alquila)sais de adição com ácido orgânico ou mineral isômeros oticamente ativos dos compostos processo para a produção de compostos e composições farmacêuticas com ação antiviral BR9506244A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9406262A FR2720397B1 (fr) 1994-05-24 1994-05-24 Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
PCT/FR1995/000683 WO1995032200A1 (fr) 1994-05-24 1995-05-24 Oxathiolanes, leur procede de preparation et les compositions pharmaceutiques qui en renferment

Publications (1)

Publication Number Publication Date
BR9506244A true BR9506244A (pt) 1997-08-12

Family

ID=9463449

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506244A BR9506244A (pt) 1994-05-24 1995-05-24 5-(Citosinil-1)1,3-oxatiolanos de configuração cis (2r-5r)compostos nicotínicos compostos dihidropirídicos compostos nicotínicos quaternizados compostos quinolênicos compostos dihidroquinoleinila compostos quinoleinilas quaternizados compsotos (dihidropiridil alquila)sais de adição com ácido orgânico ou mineral isômeros oticamente ativos dos compostos processo para a produção de compostos e composições farmacêuticas com ação antiviral

Country Status (19)

Country Link
US (1) US5708000A (pt)
EP (1) EP0733053A1 (pt)
JP (1) JPH09502453A (pt)
KR (1) KR100242891B1 (pt)
CN (1) CN1080264C (pt)
AP (1) AP612A (pt)
AU (1) AU688052B2 (pt)
BR (1) BR9506244A (pt)
CA (1) CA2167930A1 (pt)
CZ (1) CZ21996A3 (pt)
FI (1) FI960316L (pt)
FR (1) FR2720397B1 (pt)
HU (1) HU219299B (pt)
NO (1) NO306299B1 (pt)
NZ (1) NZ287478A (pt)
OA (1) OA10258A (pt)
PL (1) PL181713B1 (pt)
RU (1) RU2142462C1 (pt)
WO (1) WO1995032200A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2720397B1 (fr) * 1994-05-24 1996-08-23 Laphal Laboratoires Sa Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
IT1290447B1 (it) * 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
CN104788328B (zh) 2004-06-24 2017-09-12 沃泰克斯药物股份有限公司 Atp‑结合弹夹转运蛋白的调控剂
EP1979367A2 (en) * 2005-12-24 2008-10-15 Vertex Pharmaceuticals Incorporated Quinolin-4-one derivatives as modulators of abc transporters
WO2007079139A2 (en) 2005-12-28 2007-07-12 Vertex Pharmaceuticals, Inc. Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
UY30118A1 (es) * 2006-01-31 2007-06-29 Tanabe Seiyaku Co Compueto amina trisustituido
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
SG10201504084QA (en) 2009-03-20 2015-06-29 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
CN109966264A (zh) 2012-02-27 2019-07-05 沃泰克斯药物股份有限公司 药物组合物及其施用
US9701639B2 (en) 2014-10-07 2017-07-11 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
EP0560794B1 (en) * 1990-11-13 1996-09-18 Biochem Pharma Inc Substituted 1,3-oxathiolanes with antiviral properties
NZ241625A (en) * 1991-02-22 1996-03-26 Univ Emory 1,3-oxathiolane derivatives, anti-viral compositions containing such and method of resolving racemic mixture of enantiomers
AU1787492A (en) * 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
FR2720397B1 (fr) * 1994-05-24 1996-08-23 Laphal Laboratoires Sa Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.

Also Published As

Publication number Publication date
KR100242891B1 (ko) 2000-03-02
RU2142462C1 (ru) 1999-12-10
PL312693A1 (en) 1996-05-13
FR2720397A1 (fr) 1995-12-01
NZ287478A (en) 1997-09-22
AU2620995A (en) 1995-12-18
CZ21996A3 (en) 1996-05-15
EP0733053A1 (fr) 1996-09-25
NO306299B1 (no) 1999-10-18
AP612A (en) 1997-09-05
AU688052B2 (en) 1998-03-05
KR960703903A (ko) 1996-08-31
HU219299B (en) 2001-03-28
PL181713B1 (en) 2001-09-28
HUT75112A (en) 1997-04-28
JPH09502453A (ja) 1997-03-11
FR2720397B1 (fr) 1996-08-23
CN1080264C (zh) 2002-03-06
FI960316A7 (fi) 1996-03-22
NO960272D0 (no) 1996-01-23
FI960316L (fi) 1996-03-22
FI960316A0 (fi) 1996-01-23
WO1995032200A1 (fr) 1995-11-30
AP9600784A0 (en) 1996-04-30
NO960272L (no) 1996-01-23
US5708000A (en) 1998-01-13
OA10258A (fr) 1997-10-07
CA2167930A1 (fr) 1995-11-30
CN1130906A (zh) 1996-09-11

Similar Documents

Publication Publication Date Title
BR9506244A (pt) 5-(Citosinil-1)1,3-oxatiolanos de configuração cis (2r-5r)compostos nicotínicos compostos dihidropirídicos compostos nicotínicos quaternizados compostos quinolênicos compostos dihidroquinoleinila compostos quinoleinilas quaternizados compsotos (dihidropiridil alquila)sais de adição com ácido orgânico ou mineral isômeros oticamente ativos dos compostos processo para a produção de compostos e composições farmacêuticas com ação antiviral
BR9811685A (pt) Derivados de piridina
PT747357E (pt) Di-hidropiridinas como antagonistas de npy: derivados de piperidina
PT1000028E (pt) Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperidina substituidos nas posicoes 3 ou 4
DE69811892D1 (de) Kristalline form von omeprazol-natriumsalz
DE69923869D1 (de) Substituierte pyridine mit herbizider wirkung
PT100689A (pt) Derivados de 2-(4-hidroxipiperidino)-1-alcanol como agentes anti-isquemicos
IT1302621B1 (it) Macchina per l'applicazione di collante in zone prestabilite diprodotti in genere.
DK1103545T3 (da) 2-(3,5-bis-trifluormethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide
BR9100196A (pt) Composicao herbicida e processo para produzir derivados de uracil
PT1009436E (pt) Derivado de acridina para aumentar a biodisponibilidade oral do taxol
PT97942A (pt) Processo para a preparacao de piridino-2,3-dicarboxilato de dialquilo e de derivados do mesmo,a partir de diclorossuccinato de dialquilo
BR9106229A (pt) Pigmentos minerais amarelos,processo para a fabricacao e aplicacao de pigmentos
BR9103188A (pt) Derivado de pirimidina,processo para produzi-lo,composto e composicao herbicida
DE50115204D1 (de) Anlage zum formbearbeiten der ränder von brillengläsern
TR26798A (tr) 2-azolil nikotinat türev herbisidleri
PT1198466E (pt) Processo para producao de glifosatos ou um dos seus sais
BR9305608A (pt) Processo de fabricação de junções formadas por duas peças coladas
DE59803111D1 (de) Anlage zum formbearbeiten der ränder von brillengläsern
BR0314501A (pt) Processo para a preparação de derivado de 2-aminometilpiridina e processo para a preparação de derivado de cloridrato de piridino glicino éster
BR8901644A (pt) Processo em uma etapa para preparar bis(2,2,6,6-tetrametil-4-piperidil)amina
NO930284D0 (no) Pyridinderivater, fremgangsmaate for deres fremstilling oganvendelse derav
PT83648B (pt) Processo para a preparacao de composicoes herbicidas contendo n-(2,4-difluorofenil)-2-(3-trifluorometilfenoxi)-nicotinamida (diflufenican)
PT84411B (pt) Processo para a preparacao de 2- (2-piridil)metilsulfinil tienoimidazoles e de compostos afins, uteis como agentes anti-ulcerosos
BR9903115A (pt) Derivados de acridina

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]